Title : LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.

Pub. Date : 2019 May 3

PMID : 31053148






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
2 The present study aims to explore the involvement of lncRNA SNHG1 (small nucleolar RNA host gene 1) in sorafenib resistance and how SNHG1 is associated with overexpressed microRNA-21 (miR-21) and the activated Akt pathway, which have been demonstrated to mediate this resistance in HCC cells. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
3 Overexpressed SNHG1 contributes to sorafenib resistance by activating the Akt pathway via regulating SLC3A2. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
4 Depletion of SNHG1 enhanced the efficacy of sorafenib to induce apoptosis and autophagy of SR-HCC cells by inhibiting the activation of Akt pathway. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
5 Sorafenib induced translocation of miR-21 to the nucleus, where it promoted the expression of SNHG1, resulting in upregulation of SLC3A2, leading to the activation of Akt pathway. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
6 CONCLUSIONS: The present study has demonstrated that lncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and its nuclear expression is promoted by miR-21, whose nuclear translocation is induced by sorafenib. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
7 CONCLUSIONS: The present study has demonstrated that lncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and its nuclear expression is promoted by miR-21, whose nuclear translocation is induced by sorafenib. Sorafenib AKT serine/threonine kinase 1 Homo sapiens